Healthcare Select Sector Fund Gains 7.7% Past Year, 1.9% YTD
Healthcare Select Sector SPDR Fund delivered a 7.7% total return over the past 52 weeks, trailing the S&P 500’s 11.8% gain, and produced a 1.9% year-to-date rise, outperforming the index’s marginal decline. Among its largest constituents, Vertex Pharmaceuticals returned 6.3% over 52 weeks and 8.4% YTD, influencing XLV’s overall performance.
1. Fund Performance
The Healthcare Select Sector SPDR Fund recorded a 7.7% total return over the past 52 weeks, underperforming the S&P 500’s 11.8% benchmark gain. Year-to-date, XLV rose 1.9%, outperforming the broader market’s marginal decline and reflecting modest inflows into large-cap healthcare names.
2. Top Holdings Impact
Among XLV’s largest holdings, Vertex Pharmaceuticals contributed significant weight, with its shares up 6.3% over the past year and 8.4% year-to-date. Performance of major biotech and pharmaceutical constituents has driven overall fund returns, underscoring the impact of individual stock trends on sector ETF performance.